Simplex Trading’s Jasper Therapeutics JSPR Stock Holding History
Bought
Maintained
Sold
Other funds holding JSPR
ACA
Simplex Trading's JSPR Position: Q3 2026 in Review
Simplex Trading increased its Jasper Therapeutics (JSPR) stake by 28% in Q3 2026, buying an estimated $5.46K and bringing the position to 1,224 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6987.
Simplex Trading first reported a position in JSPR in Q4 2021 and has held it in 10 quarters since. The position peaked at $132K in Q2 2024. 35 funds tracked by Wall St. Rank hold JSPR as of Q3 2026.
- Simplex Trading held 1,224 shares of Jasper Therapeutics worth $21.3K as of Q3 2026.
- Simplex Trading bought 271 Jasper Therapeutics shares in Q3 2026, an estimated $5.46K.
- Jasper Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #6987 holding.
- Simplex Trading first reported a position in Jasper Therapeutics in Q4 2021 and has held it in 10 quarters since.
- Simplex Trading's Jasper Therapeutics position peaked at $132K in Q2 2024.
- 35 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.